Opinion | Why We’re Stuck in a Constant Cycle of Drug Shortages - The New York Times

The problem is that the generic drug system is built to be fragile. Manufacturers compete against one another for orders from price-conscious health care providers, cutting costs where they can to offer the lowest prices. This leads to a race to the bottom of minimum accepted standards, including a lack of investment in quality systems and limited redundancy...

https://www.nytimes.com/2023/12/06/opinion/drug-shortages-pharmaceuticals.html